Australia's largest stock trading and investment forum Australia's #1 stock forum

IMU

1.79%

5.5¢ imugene limited

Media Thread, page-12579

First 12579 Last

Share
Profile

Follow
kingkev

27,519 Posts.

1308

22/03/24

08:03

Post #: 73005568
Share

Originally posted by Taureanbull: ↑

Hawkbar, The company doesn’t need to arrive at its final destination for the share price to move. As I have pointed out several times, the company does want to move onto the NASDAQ. It does have major international investors watching the OASIS trial closely. The company has also employed a corporate strategist.. A lot of money has already been spent preparing for a NASDAQ listing. And we have several trial results for our platforms being released this year.

The stock market is very cable of relating a stock without seeing a big pharma deal. This company has made incredible progress in the last two years. At some stage this progress will be reflected in the share price, Whilst it may seem like it’s sat idle forever this does not predict forward shareprice movement. As with the big effort to push our clinical programs ahead, after we get the results released, the company will use these results as a catalyst to push our ahead our corporate strategy and the share price will respond accordingly.

There is a reason we are seeing this flurry of media activity. Did you also note in the last video of Leslie Chong, mentioned “ a recent presentation to US investors”. Whilst we haven’t seen a video, posted here and do not have any further information, it does hint that she is presenting to them. And it’s unlikely to be Mums and Dads . The US has a quite large and sophisticated BIOTECH focussed investment community. As opposed to Australia that has a very thin sprinkling of mums and dads.

It’s very much my experience that the SP,of a successful Biotexh will rerate rapidly when institutional investors come on board . This hasn’t happened to IMU as yet, in part because dour domestic fund managers don’t touch Biotexh. But US investors have a huge appetite for future disruptive technologies.

And that is exactly what IMU is about to unveil. The results of trials . That’s is why they dumped ALA , because our drugs are so good they don’t need ALA. All of this has been presented in the 4 videos and assorted other social media posts and announcements.

I personally got a lot from Dr Bradley Glovers presentation. And further as I shared with this board, I was lucky enough to have the opportunity to meet him and ask why he joined IMU. He reinforced his reasons again yesterday.

As he is a highly qualified expert on Celular Therapies , I’m very happy to take his word , that we have an amazing portfolio of assets here, And I’m happy to trust that major investors will see this opportunity resulting in a major relating of our share price.A Market Cap of just US$520M is clearly ridiculously low.

Expand

all good and in the meantime we hope we can hold on to 11c

IMU Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

There are more pages in this discussion • 2,320 more messages in this thread...

First 12579 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.5¢		Change -0.001(1.79%)		Mkt cap ! $404.2M

Open	High	Low	Value	Volume
5.5¢	5.6¢	5.4¢	$757.1K	13.81M

Buyers (Bids)

No.	Vol.	Price($)
16	2203877	5.4¢

Sellers (Offers)

Price($)	Vol.	No.
5.5¢	244428	4

View Market Depth

No.	Vol.	Price($)
16	2203877	0.054
24	3523105	0.053
21	1966792	0.052
18	1595967	0.051
64	5239130	0.050

Price($)	Vol.	No.
0.055	244428	4
0.056	606122	6
0.057	1272468	9
0.058	419109	6
0.059	475000	4

Last trade - 16.10pm 25/07/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-12579

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-12579

Top Stories

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News